Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,220.61 +34.89 (+2.94%)
Streaming Delayed Price Updated: 2:23 PM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,344,530
Open 1,185.01
Bid (Size) 1,220.25 (80)
Ask (Size) 1,220.98 (80)
Prev. Close 1,185.71
Today's Range 1,184.40 - 1,221.16
52wk Range 625.90 - 1,249.45
Shares Outstanding 956,580,893
Dividend Yield 0.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Eli Lilly Upgraded, Best Buy Downgraded: Updated Rankings on Top Blue-Chip Stocks ↗
During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. 
Via InvestorPlace
Eli Lilly (NYSE:LLY) Pairs High Growth Momentum with a Defined Breakout Setup ↗
Via Chartmill

Performance

YTD
+13.0%
+13.0%
1 Month
+2.7%
+2.7%
3 Month
+26.2%
+26.2%
6 Month
+16.8%
+16.8%
1 Year
+92.2%
+92.2%

More News

Read More
News headline image
Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics? ↗
Via The Motley Fool
News headline image
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? ↗
Via The Motley Fool
Topics ETFs
News headline image
Eli Lilly and Company Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026? ↗
Via The Motley Fool
Topics ETFs Economy
News headline image
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem ↗
Via The Motley Fool
News headline image
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound ↗
Via The Motley Fool
News headline image
Jim Cramer Calls This Industrial Stock ‘Sensational’ And Ameriprise Financial ‘Fantastic’ ↗
Via Benzinga
News headline image
Every S&P 500 Sector ETF Ranked by How Much It Actually Depends on Just 3 Stocks ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
Prediction: This Unstoppable Vanguard ETF Will Crush the S&P 500 in the Remainder of 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
Why Is Everyone Talking About Novo Nordisk? ↗
Via The Motley Fool
News headline image
CVS Health Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Global Abemaciclib Market to Reach USD 3.18 Billion by 2034, Growing at 9.7% CAGR ↗
Via Talk Markets
Topics Intellectual Property
SpaceX First-Quarter Print And A DeepMind Exit Split The Tape As Records Take A Breather ↗
Via Chartmill
News headline image
LLY Q2 Deep Dive: Key Products and Pipeline Expansion Offset Revenue Miss
Via StockStory
News headline image
Why Eli Lilly Stock Climbed Today ↗
Via The Motley Fool
News headline image
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026? ↗
Via The Motley Fool
Topics ETFs
News headline image
Stock Market Midday, Aug. 5: Eli Lilly Pops and AMD Drops in Mixed Morning Markets ↗
Via The Motley Fool
Topics Artificial Intelligence Earnings Stocks
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
News headline image
Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion ↗
Via Benzinga
News headline image
Eli Lilly (LLY) Stock Trades Up, Here Is Why
Via StockStory
News headline image
Nasdaq Falls Over 100 Points; Eli Lilly Shares Gain On Upbeat Earnings ↗
Via Benzinga
Topics Stocks
News headline image
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic ↗
Via MarketBeat
Topics Lawsuit
News headline image
CVS Targets Affordable GLP-1 Access With New Eli Lilly Deal ↗
Via Benzinga

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,220.61
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 08/10/26 02:23 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,167.61B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,168B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.